Skip to main content
SpringerLink
Log in

Treatment of molluscum contagiosum is more difficult in immune compromised patients

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table 1

References

  1. Smith KJ, Skelton H. Molluscum contagiosum: recent advances in pathogenic mechanisms, and new therapies. Am J Clin Dermatol 2002; 3(8): 535–45

    Article  PubMed  Google Scholar 

  2. Smith KJ, Yeager J, Skelton H. Molluscum contagiosum: its clinical, histopathologic, and immunohistochemical spectrum. Int J Dermatol 1999; 38: 664–72

    Article  PubMed  CAS  Google Scholar 

  3. Bugert JJ, Darai G. Recent advances in molluscum contagiosum virus research. Arch Virol 1997; 13: 35–47

    CAS  Google Scholar 

  4. Born TL, Morrison LA, Esteban DJ, et al. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell responses. J Immunol 2000; 164: 3246–54

    PubMed  CAS  Google Scholar 

  5. Romiti R, Ribeiro AP, Grinblat BM, et al. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol 1999; 16: 228–31

    Article  PubMed  CAS  Google Scholar 

  6. Ronnerfalt L, Fransson J, Wahlgren CF. EMLA cream provides rapid pain relief for the curettage of molluscum contagiosum in children with atopic dermatitis without causing serious application site reactions. Pediatr Dermatol 1998; 15: 309–12

    Article  PubMed  CAS  Google Scholar 

  7. Bucalo BD, Mirikitani EJ, Moy RL. Comparison of skin anesthetic effect of liposomal lidocaine, nonliposomal lidocaine and EMLA using 30-minute application time. Dermatol Surg 1998; 24: 537–41

    Article  PubMed  CAS  Google Scholar 

  8. De Clercq E. Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox-, and adenovirus) infections. Verh K Acad Geneeskd Belg 1996; 58: 19–47

    PubMed  Google Scholar 

  9. Safrin S, Cherrington J, Jaffe HS. Clinical uses of cidofovir. Rev Med Virol 1997; 7: 145–56

    Article  PubMed  CAS  Google Scholar 

  10. Zabawski EJ, Cockerell CJ. Topical cidofovir for molluscum contagiosum in children. Pediatr Dermatol 1999; 16: 414–5

    PubMed  Google Scholar 

  11. Toro JR, Wood LV, Patel NK, et al. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol 2000; 136: 983–5

    Article  PubMed  CAS  Google Scholar 

  12. Meadows KP, Tyring SK, Pavia AT, et al. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients with cidofovir. Arch Dermatol 1997; 133: 987–90

    Article  PubMed  CAS  Google Scholar 

  13. Urdiales JL, Morata P, Nunez I, et al. Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Lett 1996; 102: 31–7

    Article  PubMed  CAS  Google Scholar 

  14. Hwang Y, Rowley D, Rhodes D, et al. Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A. Mol Pharmacol 1999; 55: 1049–53

    PubMed  CAS  Google Scholar 

  15. Hourihane J, Hodges E, Smith J, et al. Interferon alpha treatment of molluscum contagiosum in immunodeficiency patients. Arch Dis Child 1999; 80: 77–9

    Article  PubMed  CAS  Google Scholar 

  16. Gross G, Roussaki A, Brzoska J. Recalcitrant molluscum contagiosum in a patient with AIDS successfully treated by a combination of CO2 laser and natural interferon beta gel. Arch Derm Venereol 1998; 78: 309–10

    Article  CAS  Google Scholar 

  17. Dohil M, Prendiville JS. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr Dermatol 1996; 15: 71–2

    Google Scholar 

  18. Syed TA, Goswani J, Ahmadpur A, et al. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% cream: a placebo-controlled, double blind study. J Dermatol 1998; 25: 309–13

    PubMed  CAS  Google Scholar 

  19. Liota E, Smith KJ, Buckley R, et al. Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 2000; 4: 76–82

    PubMed  CAS  Google Scholar 

  20. Buckley R, Smith K. Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus I disease. Arch Dermatol 1999; 135: 1167–9

    Article  PubMed  CAS  Google Scholar 

  21. Calista D, Boschini A, Landi G. Resolution of disseminated molluscum contagiosum with highly active anti-retroviral therapy (HAART) in patients with AIDS. Eur J Dermatol 1999; 9: 211–3

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treatment of molluscum contagiosum is more difficult in immune compromised patients. Drugs Ther. Perspect 19, 10–12 (2003). https://doi.org/10.2165/00042310-200319070-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200319070-00004

Keywords

Search

Navigation